- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT04902742
Comparing the Treatment Outcomes of Two Interventional Pain Procedures in Chronic Coccygodynia
Comparison of Treatment Outcomes in Chronic Coccygodynia Patients Treated With Ganglion Impar Blockade Versus Caudal Epidural Steroid Injection: A Prospective Randomized Comparison Study
Coccygodynia is a disabling pain in the coccyx exacerbated by sitting or rising from sitting. The pain is often pulling or lancinating in quality, may radiate to the sacrum or buttock, and may coexist with lower back pain. Contributing of many physiologic and psychological factors to its etiology, it may be traumatic or idiopathic in origin. Many risk factors are known such as trauma, female gender and obesity. Despite the identification of chronic coccygeal pain hundreds of years ago, its treatment can be difficult and sometimes controversial because of the multifactorial nature of coccygeal pain. Most cases of coccygodynia resolve within weeks to months with or without conservative treatment, but for a few patients, the pain can become chronic and debilitating. First-line treatment options include analgesic drugs, cushion, sit baths, and manuel therapy. Interventional procedures for pain management can be applied to patients who have no response to other conservative modalities. Ganglion impar block and caudal epidural steroid injection are two treatment options for chronic coccygodynia and both of them can be applied by guidance of fluoroscopy and ultrasonography. Radiofrequency ablation is the other option for treatment and eventually, surgical intervention can be done for patients who have refractory pain despite other treatments.
Although efficacy of two interventional procedure for chronic coccygodynia, ganglion impar block and caudal epidural steroid injection, has been well known, no study is exist comparing the efficacy of them. We aimed to compare the efficacy of ganglion impar block and caudal epidural steroid injection in chronic coccygodynia.
Panoramica dello studio
Stato
Condizioni
Descrizione dettagliata
Tipo di studio
Iscrizione (Effettivo)
Fase
- Non applicabile
Contatti e Sedi
Luoghi di studio
-
-
-
Istanbul, Tacchino, 34899
- Marmara University School of Medicine Department of Physical Medicine and Rehabilitation
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- Patients diagnosed with chronic coccygodynia between the ages of 18 and 65
- Intractable pain over the coccyx despite conservative treatment
Exclusion Criteria:
- History of ganglion impar blockade and/or caudal epidural steroid injection carried out in the last 3 months
- History of lumbar surgery
- Systemic and/or local infections
- Malignancy
- Bleeding diathesis
- Acute fracture
- Known allergy to contrast material and/or local anesthetic substances
- Known history of any psychiatric disorder
- History of pregnancy
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Doppio
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
---|---|
Comparatore attivo: Ganglion impar block group
Fluoroscopy-guided ganglion impar block is applied to patients in this group.
|
Fluoroscopy guidance is used for correct visualization of injection site, and so obtained more successful results.
Patients are placed in the prone position.
Injection site is cleaned thrice with povidone iodine %10 solution and covered with sterile drapes.
Being most commonly used technic, transsacrococcygeal technique, a 22-gauge, 1.5-inch spinal needle is advanced through the sacrococcygeal disk and positioned carefully anterior to the sacrococcygeal junction.
Injection of contrast results in a classical comma sign.
A mixture of steroid and local anesthetic is given.
|
Comparatore attivo: Caudal epidural steroid injection group
Fluoroscopy-guided caudal epidural steroid injection is applied to patients in this group.
|
Fluoroscopy guidance is used for correct visualization of injection site, and so obtained more successful results.
Patients are placed in the prone position.
Injection site is cleaned thrice with povidone iodine %10 solution and covered with sterile drapes.
An 18-gauge epidural needle (Tuohy) is advanced at an angle of 45° to the skin until a 'give-way' sensation is felt and position of the needle is confirmed by lateral and anteroposterior fluoroscopic images.
Then 5 ml of iohexol solution is injected through it to confirm the position.
A properly placed needle would produce a classical 'inverted fern tree' appearance in anteroposterior view after dye injection or a 'filling defect'.
The needle is introduced up to S3 level for proper spread of the drug.
A mixture of steroid and local anesthetics is given.
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
---|---|---|
Change in pain severity of patients from baseline to each checkpoints
Lasso di tempo: from pre-interventional time to post-interventional 1st hour, 3rd week, 3rd month
|
Defining the change in Numeric Rating Scale (NRS) score
|
from pre-interventional time to post-interventional 1st hour, 3rd week, 3rd month
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
---|---|---|
Change in number of patients with neuropathic pain from baseline to each checkpoints
Lasso di tempo: from pre-interventional time to post-interventional 3rd week, 3rd month
|
Defining the change in number of patients with neuropathic pain using Leeds Assessment of Neuropathic Symptoms and Signs Scale (LANSS)
|
from pre-interventional time to post-interventional 3rd week, 3rd month
|
Change the patient reported quality of life assessment from baseline to each checkpoints
Lasso di tempo: from pre-interventional time to post-interventional 3rd week, 3rd month
|
Defining the change in quality of life scores of patients using Short Form 12 Health Survey (SF-12)
|
from pre-interventional time to post-interventional 3rd week, 3rd month
|
Collaboratori e investigatori
Sponsor
Investigatori
- Investigatore principale: Savaş Şencan, MD, Marmara University
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Altri numeri di identificazione dello studio
- 09.2019.395
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .